In the treatment of T2DM, it is considered that management of blood glucose level through regulation of glucose transporters such as glucose transporter 2 (GLUT2), sodium-dependent glucose transporter 2 (SGLT2) (19) and GLUT4 is also effective to its amelioration. The gene discussed is SLC2A2; the disease is type 2 diabetes mellitus.